SCHEMBL7685023

SCHEMBL7685023

O=S(=O)(NCc1ccc(Cl)cc1)c1cc(Cl)c2cccnc2c1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.61
KDM4E B2RXH2 5/20 0.61
HPGD P15428 4/20 0.61
MCL1 Q07820 1/20 0.54
L3MBTL1 Q9Y468 3/20 0.51
MMP14 P50281 3/20 0.49
KMT2A Q03164 4/20 0.49
CYP3A4 P08684 3/20 0.49
LMNA P02545 3/20 0.49
MEN1 O00255 3/20 0.49
HSP90AA1 P07900 3/20 0.49
TP53 P04637 2/20 0.49
MAPT P10636 2/20 0.49
ALOX15 P16050 2/20 0.49
ALOX12 P18054 2/20 0.49
SLC6A2 P23975 2/20 0.49
OPRK1 P41145 2/20 0.49
HTT P42858 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TDP1 Q9NUW8 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7787448 0.92 KDM4E (0.64) ALDH1A1KDM4EHPGDMCL1L3MBTL1
SCHEMBL7691072 0.89 KMT2A (0.62) ALDH1A1KDM4EHPGDL3MBTL1MMP14
SCHEMBL7685010 0.86 ALDH1A1 (0.60) ALDH1A1KDM4EHPGDMCL1KMT2A
SCHEMBL7683302 0.82 MEN1 (0.58) ALDH1A1KDM4EHPGDMCL1L3MBTL1
SCHEMBL7691447 0.82 MAPT (0.51) ALDH1A1KDM4EHPGDMCL1KMT2A
SCHEMBL7686400 0.80 MCL1 (0.47) ALDH1A1KDM4EHPGDMCL1L3MBTL1
Bromide SCHEMBL7687716 0.78 ALDH1A1 (0.50) ALDH1A1KDM4EL3MBTL1MMP14KMT2A
SCHEMBL7684587 0.78 KDM4E (0.64) ALDH1A1KDM4EHPGDMCL1L3MBTL1
SCHEMBL7689196 0.78 KDM4E (0.64) ALDH1A1KDM4EHPGDMCL1KMT2A
SCHEMBL7683478 0.77 EGLN1 (0.71) ALDH1A1KDM4EHPGDL3MBTL1MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211376-B1 HERPES VIRUS, CYTOMEGALO VIRUS, VARICELLA-ZOSTER VIRUS,EPSTEIN-BARR VIRUS PHARMACIA & UPJOHN COMPANY 2001-04-03 US claimed
EP-0927164-A1 8-HYDROXY-7-SUBSTITUTED QUINOLINES AS ANTI-VIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 1999-07-07 EP claimed
WO-1998011073-A1 8-HYDROXY-7-SUBSTITUTED QUINOLINES AS ANTI-VIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 1998-03-19 WO claimed
US-6500842-B1 N-((4-CHLOROPHENYL)METHYL)-8-HYDROXY-7-QUINOLINECARBOXAMIDE ADMINISTERED AS VIRICIDES AGAINST HERPES VIRUS PHARMACIA & UPJOHN COMPANY 2002-12-31 US disclosed
US-6310211-B1 ANTI-VIRAL ACTIVITY AGAINST HERPES VIRUS, CYTOMEGALOVIRUS. MANY OF THESE COMPOUNDS ARE ALSO ACTIVE AGAINST VARICELLA ZOSTER VIRUS, EPSTEIN-BARR VIRUS, HERPES SIMPLEX VIRUS AND HUMAN HERPES VIRUS TYPE 8 PHARMACIA & UPJOHN COMPANY 2001-10-30 US disclosed
US-6252080-B1 HERPES, CYTOMEGALO VIRUS PHARMACIA & UPJOHN COMPANY 2001-06-26 US disclosed
US-6211376-B1 HERPES VIRUS, CYTOMEGALO VIRUS, VARICELLA-ZOSTER VIRUS,EPSTEIN-BARR VIRUS PHARMACIA & UPJOHN COMPANY 2001-04-03 US disclosed
EP-0927164-A1 8-HYDROXY-7-SUBSTITUTED QUINOLINES AS ANTI-VIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 1999-07-07 EP disclosed
WO-1998011073-A1 8-HYDROXY-7-SUBSTITUTED QUINOLINES AS ANTI-VIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 1998-03-19 WO disclosed